7 (July 2006)
Spotlight Interview: Robert Wood Johnson University Hospital
- Thu, 5/1/08 - 4:22pm
- 0 Comments
- 3146 reads
What is the size of your EP lab facility and number of staff members? What is the mix of credentials at your lab?
50th Anniversary of Defibrillation: Paul M. Zoll, MD and the Beginning of ZOLL Medical Corporation
- Thu, 5/1/08 - 4:22pm
- 0 Comments
- 3556 reads
My father Paul Zoll had a long and distinguished research career. A good summary is on the Heart Rhythm Society's website (http://www.hrsonline.org/ep-history/notable_figures/bios/paul_zoll/). His research was in the setting of an active private practice, and his practice was the source of his inspiration and incentive, as well as unending distractions. Every time he tried to do anything, he was constantly interrupted by clinical issues with various patients. He was totally committed to taking the best care of his patients, though. He was very demanding of the hospital staff and attentive to his patients. He presented a gruff demeanor as necessary, but it was totally an act. He had a wry wit. He was full clinical professor at Harvard Medical School at the Beth Israel Hospital. He continued this active research program with many collaborators. He was also the editor of Circulation for many years.
A Clinical Ladder for Cath Lab Personnel
- Thu, 5/1/08 - 4:22pm
- 0 Comments
- 2302 reads
10-Minute Interview: Michael Weiner, CEO, Biophan Technologies, Inc.
- Thu, 5/1/08 - 4:22pm
- 0 Comments
- 2188 reads
Describe U.S. Patent 7,020,517 (Fibrillation/Tachycardia Monitoring and Preventive System and Methodology). How does the technology work? How will incorporating a circuit prevent/detect the potential onset of ventricular fibrillation? What are some of the benefits of implementing this patent's technology in devices?
Email Discussion Group: July 2006
- Thu, 5/1/08 - 4:22pm
- 0 Comments
- 1692 reads
Complication Rates Associated with ICD Generator Replacement: Interview with Dr. Andrew Krahn
- Sat, 5/3/08 - 1:47pm
- 0 Comments
- 1660 reads
What prompted you to begin studying complication rates in the ICD patient population? Since replacing a defibrillator is generally considered a "minor" procedure, had you noticed an increase in complication rates among your patients?
We are a regional centre for lead extraction for patients with infected devices. In the Fall of 2005, we saw three patients who developed significant infection after advisory device replacement over the course of a month. All three of these patients came to London Health Sciences Centre for lead extraction, with death as a complication of lead extraction in one. This prompted us to assess the downside of advisory device replacement and initiate a study to look at the scope of the problem.
Describe the study results. How many and what types of complications occurred? How many follow-up surgeries were needed? In addition, how many patients ultimately had their devices replaced?
Single-Center Experience of Deep Sedation with Non-Anesthesia Trained EP Lab Personnel: It's About Time
- Sat, 5/3/08 - 1:47pm
- 0 Comments
- 2417 reads
The EP Lab at Providence Hospital in Southfield, Michigan has been using deep sedation for over eight years without anesthesia. There have been many articles about the use of conscious sedation and far less deep sedation for various procedures in the clinical electrophysiology setting without the use of anesthesia personnel. What set our department apart was the fact that we use a medication called propofol (Diprivan). In Michigan, this medication is used almost exclusively by anesthesia. All the literature that we researched, whether using conscious sedation or deep sedation without the use of anesthesia, used only benzodiazepines and opiates.
Device Technology Update
- Sat, 5/3/08 - 1:47pm
- 0 Comments
- 939 reads
Dear readers, This month we shift our focus to device technology. Specifically, we attempt to answer these questions:
1) how far have we come;
2) what do we still need to work on; and
3) what is on the horizon?





